Navigation Links
New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma
Date:7/1/2009

Priority is collaborating effectively with government and NGO partners and strengthening the supply chain for delivering Pfizer-donated Zithromax

ATLANTA, July 1 /PRNewswire-USNewswire/ -- The International Trachoma Initiative (ITI) has a new leadership team focused on creating effective collaborations among governments and NGOs in 56 trachoma endemic countries. Through stronger partnerships, ITI hopes to support local, national, regional, and international groups in reaching the goal of eliminating blinding trachoma globally by 2020. The leadership team has extensive experience in trachoma programming and addressing Neglected Tropical Diseases (NTDs).

"We see ITI as a partner among partners in the global trachoma community," said Dr. Danny Haddad, ITI Director. "Governments and NGOs are committed to implementing the SAFE strategy -- Surgery, Antibiotics, Facial cleanliness, and Environmental improvements -- used to treat and prevent trachoma. We are setting up a Trachoma Expert Committee with experts in water, sanitation, health communications and surgery."

When ITI merged with the Task Force for Global Health in April 2009, Jeffrey B. Kindler, the Chairman and CEO of Pfizer, which supplies the antibiotic Zithromax that treats and prevents trachoma, stated, "We look forward to continuing our support and working through ITI and its Trachoma Expert Committee to provide the Zithromax that will be needed to eliminate blinding trachoma by 2020 and restore the health and well-being of families now and generations to come."

"The Zithromax drug donation program remains the key priority," said Haddad. "With this renewed commitment from Pfizer, our top goal is to make sure that Zithromax is distributed on time and in the right quantity to our partner countries."

Dr. Haddad is joined by four key staff members:

  • Associate Director Lisa Rotondo has extensive public health program management and evaluation experience, with an emphasis on trachoma and other NTDs in Africa.
  • Supply Chain Manager Vivian Singletary has worked over 15 years on managing supply chain optimization projects, including mid- to long-term strategy, IT system implementations and process improvement.
  • Project Manger PJ Hooper, who oversees a Gates Foundation grant supporting NTD integration research, has conducted operational research on Lymphatic Filariasis and NTDs for another Gates grant to the Global Alliance to Eliminate LF.
  • Program Accounting Manager Edward Nyankson has 16 years experience in accounting and financial reporting, tax, securities exchange and regulatory reporting.

ITI has program offices in Ethiopia, Ghana, Mali, Niger, Tanzania and Vietnam.

www.trachoma.org


'/>"/>
SOURCE The International Trachoma Initiative (ITI)
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
2. Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry
3. KGI and Smith College Establish Leadership Forum for Women in Bioscience
4. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
5. Assay Designs(TM) Announces Additions to the Leadership Team
6. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
7. Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala
8. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
9. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
10. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
11. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... ... A recent survey conducted by the Weed Science Society of America (WSSA) ranks ... of broadleaf crops, fruits and vegetables, while common lambsquarters ranks as the weed most ... the 2016 survey, the second conducted by WSSA. A 2015 baseline survey explored ...
(Date:5/23/2017)... ... , ... Vortex Biosciences , provider of circulating tumor cell (CTC) capture ... using Vortex microfluidic technology ” in Nature Precision Oncology on May 8th. The ... and Dr. Matthew Rettig at the University of California, Los Angeles. The publication describes ...
(Date:5/23/2017)... ... 23, 2017 , ... Customers often prefer PLC and ... again. METTLER TOLEDO has released two new videos that show how they have ... the ACT350 into Siemens and Allen Bradley PLCs is easy and fast. ...
(Date:5/21/2017)... Diego, CA (PRWEB) , ... May 20, 2017 ... ... support tool that helps avoid the lengthy trial and error process by finding ... patients. It can also strengthen the doctor-patient relationship through a personalized approach ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... 2017 The report "Video Surveillance ... Servers, Storage Devices), Software (Video Analytics, VMS), and Service ... Forecast to 2022", published by MarketsandMarkets, the market was ... projected to reach USD 75.64 Billion by 2022, at ... base year considered for the study is 2016 and ...
Breaking Biology News(10 mins):